Gomekli
NDC 82448-130, mirdametinib, capsule, from SpringWorks Therapeutics, Inc..
- Product NDC
- 82448-130
- Status
- Listed
- Labeler
- SpringWorks Therapeutics, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219389
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82448-130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MIRDAMETINIB1 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]; Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82448-130-42 | 82448013042 | 42 CAPSULE in 1 BOTTLE (82448-130-42) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4c41bf90-5fa7-4935-a95c-e047ea6bbf8e
Use it
Look up 82448-130 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82448-130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82448-130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.